Google Chrome
Safari
Firefox
Edge
Search
Article / Oct 20, 2020
The Coronavirus Crisis: Challenges and Opportunities for CMOs, CDMOs and CROs
CheManager, 20 October 2020
Article / Sep 27, 2021
How the drug services industry found itself prepared for a pandemic
C&EN, 26 September 2021
Press Release / Mar 18, 2024
Hovione and GEA Strengthen Partnership to Advance Continuous Tableting Technology
The agreement furthers Hovione´s ability to bring the benefits of continuous tableting, including reduced time to market and increased supply chain flexibility, to pharmaceutical customers globally
Press Clipping / Nov 12, 2018
How Hovione grew from a basement lab to a global pharmaceutical services company
C&EN, November 12, 2018
Press Release / Mar 17, 2021
Hovione completes its Phase 2 clinical trial of the first minocycline ophthalmic
Showing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction
Press Release / Feb 22, 2022
Hovione and Zerion Pharma announce a strategic partnership to market the Dispersome® technology platform
Hovione, the leader in spray drying and particle engineering, announced today a strategic partnership with Zerion Pharma to market and commercialize Dispersome®, Zerion´s proprietary solubility enhancement technology platform.
Press Release / Sep 23, 2020
Hovione Announces Partnership to Support Manufacturing of Antiviral Veklury® for COVID-19
Hovione today announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®